SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-042492
Filing Date
2023-12-21
Accepted
2023-12-21 16:04:27
Documents
1
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1703192659.html 4  
1 FORM 4 wk-form4_1703192659.xml 4 3889
  Complete submission text file 0001628280-23-042492.txt   5479
Mailing Address C/O BRAINSTORM CELL THERAPEUTICS INC. 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address
Almenoff June Sherie (Reporting) CIK: 0001492647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 231505288

Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)